Suppliers / Pharbil Waltrop

Pharbil Waltrop

Germany Updated 9 July 2026

Pharbil Waltrop is a finished-dose manufacturer based in Germany. It appears in 12 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, EDE (AE) and ARCSA (EC). Its GMP standing is certified by ZLG (DE) and EMA. Its most recent recorded inspection, by US FDA, closed on 14 February 2020 as VAI.

0
active US DMFs
0
valid CEPs
5
registered plants 1 with an FDA FEI number
12
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 February 2020 VAI US FDA
  • 22 June 2018 VAI US FDA
  • 24 January 2014 NAI US FDA
  • 30 October 2008 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Waltrop, United Arab Emirates Not on file
WALTROP, Germany Not on file
Nordrhein-Westfalen, Germany Not on file
Germany, Germany 3004620586
North Rhine-Westphalia, Germany Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 5 3
EDE (AE) 2 None
ARCSA (EC) 2 None
NPRA (MY) 1 None
UZPHARM (UZ) 1 None
DIGEMAPS (DO) 1 None
ZLG (DE) None 12

Comparing suppliers?

Choose your molecules and target markets. Pharbil Waltrop comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 February 2020.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates